Search

Drug Firm Lupin received USFDA approval to market HIV drug Prezista tablets

The tablets with chemical name Darunavir Ethanolate will be used to treat HIV-1 infection.

Dec 31, 2014 16:37 IST
facebook IconTwitter IconWhatsapp Icon

Drug firm Lupin on 30 December 2014 received the approval from the United States Food and Drugs Administration (USFDA) to market its generic drug Prezista tablets in the US. The tablets with chemical name Darunavir Ethanolate will be used to treat HIV-1 infection.

Earlier, the company had also received USFDA approval to market a generic version of ViiV Healthcare’s Epivir Tablets, used in treating HIV infection, in the American market.

About Lupin

The company is headquartered in Mumbai, India. Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations for the developed and developing markets of the world.

Download our Current Affairs & GK app For exam preparation

डाउनलोड करें करेंट अफेयर्स ऐप एग्जाम की तैयारी के लिए

AndroidIOS